Evidence-based Complementary and Alternative Medicine · 2012 · 53 citations · 34 references
MedicinePharmacologyPharmacotherapyBiochemical PharmacologyCell SignalingMolecular PharmacologyAntifibrotic TherapyFibrosisHepatic FibrosisHepatic PathophysiologyLiver DiseaseActivated Hepatic Stellate CellsErk SignalingFibrotic ChangeHepatic Stellate Cell BiologyRenin-angiotensin System In FibrosisRenin-angiotensin System ModulationTransforming Growth Factor Beta RegulationTransforming Growth Factor-beta Signaling
The renin-angiotensin system (RAS) plays an important role in hepatic fibrosis. Salvianolic acid B (Sal B), one of the water-soluble components from Radix Salviae miltiorrhizae, has been used to treat hepatic fibrosis, but it is still not clear whether the effect of Sal B is related to angiotensin II (Ang II) signaling pathway. In the present study, we studied Sal B effect on rat liver fibrosis and Ang-II related signaling mediators in dimethylnitrosamine-(DMN-) induced rat fibrotic model in vivo and Ang-II stimulated hepatic stellate cells (HSCs) in vitro, with perindopril or losartan as control drug, respectively. The results showed that Sal B and perindopril inhibited rat hepatic fibrosis and reduced expression of Ang II receptor type 1 (AT1R) and ERK activation in fibrotic liver. Sal B and losartan also inhibited Ang II-stimulated HSC activation including cell proliferation and expression of type I collagen I (Col-I) and α-smooth muscle actin (α-SMA) production in vitro, reduced the gene expression of transforming growth factor beta (TGF-β), and downregulated AT1R expression and ERK and c-Jun phosphorylation. In conclusion, our results indicate that Sal B may exert an antihepatic fibrosis effect via downregulating Ang II signaling in HSC activation.
34
Ramón Bataller · Journal of Clinical Investigation · 2005 · 1.5K citations · Full text
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
Ramón Bataller, Pere Ginès, Josep M. Nicolás et al. · Gastroenterology · 2000 · 495 citations · Full text
Host genetic factors influence disease progression in chronic hepatitis C
Elizabeth E. Powell, Catherine Edwards-Smith, John L. Hay et al. · Hepatology · 2000 · 400 citations · Full text